Skip to content

The Use of an Anal-Tape in Patients With Fecal Incontinence

The Use of an Anal-Tape in Patients With Fecal Incontinence

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02989545
Enrollment
20
Registered
2016-12-12
Start date
2016-12-31
Completion date
2018-12-31
Last updated
2020-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fecal Incontinence

Brief summary

Fecal incontinence (FI), defined as the involuntary passage of stool for more than 3 months and is a devastating disease. The negative impact on quality of life has been consistently demonstrated. The prevalence of FI is probably underestimated in most studies. Currently conservative treatment is only modestly effective and surgical treatment is complex and expensive with less than optimal efficacy. The investigators developed an anal tape using a commercially available elastic band with a special adhesive that is approved for use in the skin. A special design of the tape can be applied to the skin surrounding the anus providing support and additional pressure forces to the anal sphincter. This is a 4 week, prospective, non blinded, cross-over study to explore the efficacy and safety of this device in patients with FI. The primary endpoint will be improvement in quality of life.

Interventions

DEVICEAnal Tape

Sponsors

Shaare Zedek Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>18 years old * Fecal incontinence for more than 6 months * Willing to participate * Understand the study procedures * Is able to apply and remove the anal tape without significant assistance of others. * Have done sigmoidsocopy or colonoscopy and anal manometry within five year of screening visit

Exclusion criteria

* Advanced full thickness rectal prolapse. * Injured, inflamed or any significant disease in the peri-anal skin. * Allergy to any component of the device, either known or developed during testing in the screening visit. * Moderate to severe proctitis of any etiology.

Design outcomes

Primary

MeasureTime frameDescription
Any Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)2 weeksThe FIQoL is a validated, condition-specific tool that evaluates quality of life (QoL) in patients with fecal incontinence (FI) it consisting of 29 questions, subdivided into four domains: Lifestyle, Coping/Behavior, Depression/Self-perception, and Embarrassment. Item 1, general health, is graded from 1 excellent to 5 poor and is reversely scored. Items 2 to 28 are graded on a 4-point Likert-scale (1 = lower QoL). Item 29, FI specific depression, is graded from 1 extremely so to 6 not at all. The average score for each domain is calculated separately and is calculated only if half or more of the items in the particular domain have been answered. Scales range from 1 to 5, with a 1 indicating a lower quality of life. Each domain or subscale is reported separately (Range 1 to 5), a total score including all four domains is not calculated.

Secondary

MeasureTime frameDescription
A 50% Reduction in the Number of Episodes of FI Per Week4 weeksNumber of pateints with reduction of more than 50% in the absolute number of FI events during each week of the study
Mean Wexner Score2 weeksThe Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.
Mean Redction in Wexner Scale Compared to Baseline2 weeksThe Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.
General Satisfaction2 weeksGeneral satisfaction with the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their satisfaction with the device between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.
Willingness of the Patient to Continue Using the Anal Tape After the Study.4 weeksWillingness of the patient to continue using the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their willingness to use the device in the future between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.

Participant flow

Participants by arm

ArmCount
All Patients
2 week period without intervention then 2 week period with anal tape intervention
20
Total20

Baseline characteristics

CharacteristicAll Patients
Age, Continuous64 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
20 Participants
Race (NIH/OMB)
White
0 Participants
Sex: Female, Male
Female
20 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 203 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Any Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)

The FIQoL is a validated, condition-specific tool that evaluates quality of life (QoL) in patients with fecal incontinence (FI) it consisting of 29 questions, subdivided into four domains: Lifestyle, Coping/Behavior, Depression/Self-perception, and Embarrassment. Item 1, general health, is graded from 1 excellent to 5 poor and is reversely scored. Items 2 to 28 are graded on a 4-point Likert-scale (1 = lower QoL). Item 29, FI specific depression, is graded from 1 extremely so to 6 not at all. The average score for each domain is calculated separately and is calculated only if half or more of the items in the particular domain have been answered. Scales range from 1 to 5, with a 1 indicating a lower quality of life. Each domain or subscale is reported separately (Range 1 to 5), a total score including all four domains is not calculated.

Time frame: 2 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Off TreatmentAny Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)Lifestyle2.8 score on a scaleStandard Deviation 0.69
Off TreatmentAny Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)Coping/Behaivoir1.9 score on a scaleStandard Deviation 0.64
Off TreatmentAny Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)Depression/Self-Perception3.1 score on a scaleStandard Deviation 0.75
Off TreatmentAny Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)Embarrassment2.13 score on a scaleStandard Deviation 0.67
Treatment PeriodAny Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)Embarrassment2.65 score on a scaleStandard Deviation 0.76
Treatment PeriodAny Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)Lifestyle3.3 score on a scaleStandard Deviation 0.68
Treatment PeriodAny Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)Depression/Self-Perception3.5 score on a scaleStandard Deviation 0.74
Treatment PeriodAny Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)Coping/Behaivoir2.5 score on a scaleStandard Deviation 0.73
Secondary

A 50% Reduction in the Number of Episodes of FI Per Week

Number of pateints with reduction of more than 50% in the absolute number of FI events during each week of the study

Time frame: 4 weeks

Population: Note that this outcome was obtained by free text stool diaries that patients had to keep at home. Only 15 patient out of 20 provided full diaries, therefore the analysis is limited to 15 instead of all 20.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Off TreatmentA 50% Reduction in the Number of Episodes of FI Per Week0 Participants
Treatment PeriodA 50% Reduction in the Number of Episodes of FI Per Week5 Participants
Secondary

General Satisfaction

General satisfaction with the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their satisfaction with the device between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.

Time frame: 2 weeks

Population: Note that in 3 patients these data were missing, therefore the analysis if for 17 out of 20 participants.

ArmMeasureValue (MEDIAN)
Off TreatmentGeneral Satisfaction80 mm in VAS scale
Secondary

Mean Redction in Wexner Scale Compared to Baseline

The Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Off TreatmentMean Redction in Wexner Scale Compared to Baseline0.6 score on a scaleStandard Deviation 1.7
Treatment PeriodMean Redction in Wexner Scale Compared to Baseline1.95 score on a scaleStandard Deviation 4.2
Secondary

Mean Wexner Score

The Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Off TreatmentMean Wexner Score11.9 score on a scaleStandard Deviation 3.5
Treatment PeriodMean Wexner Score10.3 score on a scaleStandard Deviation 4.8
Secondary

Willingness of the Patient to Continue Using the Anal Tape After the Study.

Willingness of the patient to continue using the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their willingness to use the device in the future between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.

Time frame: 4 weeks

Population: Note that in 3 patients these data were missing, therefore the analysis if for 17 out of 20 participants.

ArmMeasureValue (MEDIAN)
Off TreatmentWillingness of the Patient to Continue Using the Anal Tape After the Study.90 mm in VAS scale

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026